Samorita Hospital Limited (DSE: SAMORITA)
Bangladesh
· Delayed Price · Currency is BDT
73.90
+2.20 (3.07%)
At close: Sep 12, 2024
Samorita Hospital Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
Revenue | 377.62 | 334.27 | 338.09 | 393.62 | 321.23 | 374.39 | Upgrade
|
Revenue Growth (YoY) | 18.98% | -1.13% | -14.11% | 22.53% | -14.20% | 1.13% | Upgrade
|
Cost of Revenue | 164.52 | 145.76 | 148.05 | 172.75 | 142.32 | 166.42 | Upgrade
|
Gross Profit | 213.1 | 188.5 | 190.04 | 220.87 | 178.92 | 207.97 | Upgrade
|
Selling, General & Admin | 166.94 | 157.9 | 141.97 | 147.25 | 171.04 | 147.49 | Upgrade
|
Other Operating Expenses | 1.87 | 1.87 | 0.64 | 0.12 | 0.16 | 0.09 | Upgrade
|
Operating Expenses | 194.96 | 184.72 | 165.63 | 171.7 | 174.55 | 171.11 | Upgrade
|
Operating Income | 18.14 | 3.78 | 24.41 | 49.17 | 4.37 | 36.85 | Upgrade
|
Interest Expense | -5.18 | -6.05 | -6.93 | - | - | - | Upgrade
|
Interest & Investment Income | 2.06 | 2.44 | 3.67 | 4.04 | 6.37 | 6.29 | Upgrade
|
Earnings From Equity Investments | 0.02 | 0.04 | 0.04 | -0.07 | -0.49 | 0.06 | Upgrade
|
Other Non Operating Income (Expenses) | 2.47 | 2.86 | 2.84 | 1.46 | 2.26 | 0.63 | Upgrade
|
EBT Excluding Unusual Items | 17.52 | 3.07 | 24.03 | 54.61 | 12.51 | 43.83 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.31 | -0.07 | -2.23 | -0.11 | Upgrade
|
Pretax Income | 17.55 | 3.1 | 24.34 | 54.53 | 10.28 | 43.72 | Upgrade
|
Income Tax Expense | 5.4 | 2.38 | 8.04 | 12.44 | 7.03 | 11.49 | Upgrade
|
Net Income | 12.15 | 0.72 | 16.29 | 42.09 | 3.25 | 32.24 | Upgrade
|
Net Income to Common | 12.15 | 0.72 | 16.29 | 42.09 | 3.25 | 32.24 | Upgrade
|
Net Income Growth | 1179.23% | -95.58% | -61.29% | 1193.89% | -89.91% | 36.49% | Upgrade
|
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade
|
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade
|
Shares Change (YoY) | -0.00% | - | -0.00% | - | - | -0.00% | Upgrade
|
EPS (Basic) | 0.56 | 0.03 | 0.75 | 1.93 | 0.15 | 1.48 | Upgrade
|
EPS (Diluted) | 0.56 | 0.03 | 0.75 | 1.93 | 0.15 | 1.48 | Upgrade
|
EPS Growth | 1179.27% | -95.58% | -61.29% | 1193.89% | -89.91% | 36.49% | Upgrade
|
Free Cash Flow | 23.03 | -0.04 | -11.26 | -21.62 | -48.32 | 41.21 | Upgrade
|
Free Cash Flow Per Share | 1.06 | -0.00 | -0.52 | -0.99 | -2.22 | 1.89 | Upgrade
|
Dividend Per Share | - | - | 0.433 | 0.866 | - | 0.825 | Upgrade
|
Dividend Growth | - | - | -50.00% | - | - | -16.66% | Upgrade
|
Gross Margin | 56.43% | 56.39% | 56.21% | 56.11% | 55.70% | 55.55% | Upgrade
|
Operating Margin | 4.80% | 1.13% | 7.22% | 12.49% | 1.36% | 9.84% | Upgrade
|
Profit Margin | 3.22% | 0.22% | 4.82% | 10.69% | 1.01% | 8.61% | Upgrade
|
Free Cash Flow Margin | 6.10% | -0.01% | -3.33% | -5.49% | -15.04% | 11.01% | Upgrade
|
EBITDA | 41.1 | 26.82 | 44.27 | 69.81 | 24.34 | 58.18 | Upgrade
|
EBITDA Margin | 10.88% | 8.02% | 13.09% | 17.74% | 7.58% | 15.54% | Upgrade
|
D&A For EBITDA | 22.96 | 23.04 | 19.86 | 20.64 | 19.97 | 21.32 | Upgrade
|
EBIT | 18.14 | 3.78 | 24.41 | 49.17 | 4.37 | 36.85 | Upgrade
|
EBIT Margin | 4.80% | 1.13% | 7.22% | 12.49% | 1.36% | 9.84% | Upgrade
|
Effective Tax Rate | 30.77% | 76.76% | 33.06% | 22.82% | 68.36% | 26.27% | Upgrade
|
Advertising Expenses | - | 1.02 | 0.93 | 1.01 | 2.36 | 2.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.